Core Insights - Lepu Medical (300003) reported a closing price of 15.61 yuan as of July 29, 2025, with a 1.1% increase and a turnover rate of 3.05% [1] - The company experienced a net outflow of main funds amounting to 44.29 million yuan, representing 5.81% of the total transaction amount [1] Financial Performance - For Q1 2025, Lepu Medical's total operating revenue was 1.736 billion yuan, a year-on-year decrease of 9.67% [1] - The net profit attributable to shareholders was 379 million yuan, down 21.44% year-on-year [1] - The non-recurring net profit was 337 million yuan, reflecting a 26.08% decrease compared to the previous year [1] - The current ratio stood at 1.817, the quick ratio at 1.418, and the debt-to-asset ratio was 32.00% [1] Company Overview - Lepu Medical (Beijing) Co., Ltd. was established in 1999 and is primarily engaged in the pharmaceutical manufacturing industry [2] - The company has a registered capital of 1.88061 billion yuan and a paid-in capital of 699.707 million yuan [1] - The legal representative of the company is Pu Zhongjie [1] Investment and Intellectual Property - Lepu Medical has made investments in 81 companies and participated in 832 bidding projects [2] - The company holds 1,310 trademark registrations and 394 patents, along with 110 administrative licenses [2]
乐普医疗(300003)7月29日主力资金净流出4428.82万元